We are delighted to announce that Spex Capital and MedCity have signed an exclusive partnership to identify and fund promising health tech ventures, accelerating their route to commercialisation and uptake in healthcare systems globally.

The partnership aims to support several calls for innovative companies seeking seed and Series A stage investment.

Joining forces with MedCity, who has extensive established networks across the UK ecosystem and with international life science clusters, Spex Capital will be able to amplify its proposition to health tech entrepreneurs and truly implement change in digital health and medtech.

September marks the date of the first call, where tickets between £500,000 and £5,000,000 will be offered to the most promising companies.

Our Founder and Managing Director Claudio D’Angelo comments “There is an incredible pool of talent with unexpressed potential in digital health and med tech, but many innovative ventures in the sector don’t get access to the appropriate opportunities in their early stages due to lack of funds and track record. This is where Spex Capital comes in. Specialised in advancing disruptive early-stage ventures, our goal is to deliver breakthroughs in healthcare systems globally. I’m glad to be working again with MedCity on an exclusive basis with my new venture. We’ve fine-tuned the process over the years to deliver a more efficient reviewal process and I’m excited to see what this call will yield in terms of talent”

MedCity COO Nicki Bromwich views the partnership as a natural alignment of shared interests, adding: “Through its funding of transformative health tech, Spex Capital is allied with MedCity’s own mission of supercharging innovation and driving investment into the life sciences sector to ultimately improve human health and patient outcomes.“

Based in London and leveraging its global reach in the sector, Spex Capital is unique in its genre for the international proposition it offers to health-tech entrepreneurs and investors. Ahead of launch, the firm has already established a world-class ecosystem via partnerships and relationships with accelerators and incubators, universities, hospitals, embassies, chambers of commerce, trade bodies, payors and healthcare systems across all continents to source the highest quality technologies worldwide.